human clinical trials bpc 157 athletic performance The Future of Body Re-composition and Bodybuilding: How Prof. Mike Chan's Peptide Research is Transforming BPC-157 and the Difference Between
Description
Mater Today Energy 19:100589

The difference is the target
Foot Ankle Clin 12:553567 Hsieh MJ, Liu HT, Wang CN, Huang HY, Lin Y, Ko YS, Wang JS, Chang VH, Pang JH (2017) Therapeutic potential of pro-angiogenic BPC157 is associated with VEGFR2 activation and up-regulation

Remarkably, the same narrow dose range proves effective whether counteracting dopamine depletion, serotonin syndrome, glutamate excitotoxicity, or GABA tolerance
